Q3 2024 · 13F-HR
Sofinnova Investments, Inc.holdings as filed
Filed 2024-11-13 · accession 0001104659-24-117589
$1.26B
Reported value
60
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 632307104 | NTRA | Natera Inc | $196.8M | 15.6% | 1,550,280 | Common | SOLE |
| 92337R101 | VERA | Vera Therapeutics Inc | $123.5M | 9.80% | 2,793,987 | Common | SOLE |
| 670100205 | NVO | Novo-Nordisk A S | $86.5M | 6.86% | 726,329 | Common | SOLE |
| 046353108 | AZNN | AstraZeneca PLC | $63.1M | 5.00% | 809,406 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA Biosciences Inc | $55.4M | 4.40% | 1,749,455 | Common | SOLE |
| 28414H103 | ELAN | Elanco Animal Health Inc | $51.7M | 4.10% | 3,518,684 | Common | SOLE |
| 09077V100 | BIOA | BioAge Labs Inc | $47.9M | 3.80% | 2,304,901 | Common | SOLE |
| 45337C102 | INCY | Incyte Corp | $47.2M | 3.75% | 714,176 | Common | SOLE |
| 75383L102 | RAPP | Rapport Therapeutics Inc | $40.9M | 3.24% | 1,995,594 | Common | SOLE |
| 04272N102 | AVBP | Arrivent BioPharma Inc | $39.9M | 3.16% | 1,696,752 | Common | SOLE |
| 05464T104 | AXSM | Axsome Therapeutics Inc | $34.1M | 2.71% | 379,527 | Common | SOLE |
| 834203309 | SLNO | Soleno Therapeutics Inc | $29.6M | 2.35% | 586,344 | Common | SOLE |
| 984241109 | YMABUSD | Y-mAbs Therapeutics Inc | $28.9M | 2.29% | 2,194,278 | Common | SOLE |
| 26818M108 | DYN | Dyne Therapeutics Inc | $27.7M | 2.20% | 772,070 | Common | SOLE |
| 19240Q201 | COGT | Cogent Biosciences Inc | $24.5M | 1.94% | 2,265,230 | Common | SOLE |
| 805111101 | SVRA | Savara Inc | $24.0M | 1.91% | 5,662,550 | Common | SOLE |
| 66987V109 | NVS | Novartis AG | $23.0M | 1.83% | 200,000 | PUT | SOLE |
| 45790W108 | — | Inozyme Pharma Inc | $22.4M | 1.78% | 4,280,308 | Common | SOLE |
| G50871105 | JAZZ | Jazz Pharmaceuticals PLC | $21.0M | 1.67% | 188,562 | Common | SOLE |
| 457669307 | INSM | Insmed Inc | $20.9M | 1.66% | 286,307 | Common | SOLE |
| 87164F105 | SNDX | Syndax Pharmaceuticals Inc | $15.1M | 1.20% | 786,999 | Common | SOLE |
| 834203309 | SLNO | Soleno Therapeutics Inc | $15.1M | 1.20% | 300,000 | PUT | SOLE |
| 76243J105 | RYTM | Rhythm Pharmaceuticals | $14.5M | 1.15% | 276,678 | Common | SOLE |
| 05464T104 | AXSM | Axsome Therapeutics Inc | $13.5M | 1.07% | 150,000 | PUT | SOLE |
| 28176E108 | EW | Edwards Lifesciences Corp | $13.4M | 1.06% | 202,898 | Common | SOLE |
| 101137107 | BSX | Boston Scientific Corp | $11.4M | 0.90% | 135,819 | Common | SOLE |
| N69605108 | PHVS | Pharvaris N V | $11.1M | 0.88% | 600,302 | Common | SOLE |
| 28036F105 | EWTX | Edgewise Therapeutics Inc | $10.3M | 0.82% | 384,767 | Common | SOLE |
| 45257U108 | IMNM | Immunome Inc | $9.9M | 0.79% | 676,766 | Common | SOLE |
| 40131M109 | GH | Guardant Health Inc | $9.3M | 0.74% | 406,645 | Common | SOLE |
| 76155X100 | RVMD | Revolution Medicines Inc | $9.2M | 0.73% | 203,271 | Common | SOLE |
| 45720N103 | INBX | Inhibrx Biosciences Inc | $8.4M | 0.67% | 536,068 | Common | SOLE |
| 88322Q108 | TGTX | TG Therapeutics Inc | $8.4M | 0.67% | 358,644 | Common | SOLE |
| 008064107 | — | Aerovate Therapeutics Inc | $7.9M | 0.62% | 3,758,686 | Common | SOLE |
| G31249108 | ESTA | Establishment Labs Hldgs Inc | $7.9M | 0.62% | 181,476 | Common | SOLE |
| 56854Q200 | MRNS* | Marinus Pharmaceuticals Inc | $7.7M | 0.61% | 4,386,177 | Common | SOLE |
| 47103J105 | JANX | Janux Therapeutics Inc | $7.5M | 0.59% | 164,770 | Common | SOLE |
| 12674W109 | CABA | Cabaletta Bio Inc | $7.2M | 0.57% | 1,533,883 | Common | SOLE |
| 004468500 | ACHV | Achieve Life Sciences Inc | $7.2M | 0.57% | 1,514,032 | Common | SOLE |
| 50127T109 | KURA | Kura Oncology Inc | $5.8M | 0.46% | 296,884 | Common | SOLE |
| 71742Q106 | PAHC | Phibro Animal Health Corp | $5.4M | 0.43% | 238,184 | Common | SOLE |
| 452327109 | ILMN | Illumina Inc | $5.3M | 0.42% | 40,611 | Common | SOLE |
| 29479A108 | ERAS | Erasca Inc | $5.0M | 0.40% | 1,842,668 | Common | SOLE |
| N44445109 | IMTX | Immatics N.V | $4.4M | 0.35% | 386,100 | Common | SOLE |
| 45332Y109 | NARIUSD | Inari Med Inc | $3.7M | 0.30% | 90,327 | Common | SOLE |
| 075887109 | BDX | Becton Dickinson & Co | $3.7M | 0.29% | 15,191 | Common | SOLE |
| 65343E108 | NXTCEUR | Nextcure Inc | $3.7M | 0.29% | 2,671,856 | Common | SOLE |
| 883556102 | TMO | Thermo Fisher Scientific Inc | $3.6M | 0.28% | 5,770 | Common | SOLE |
| 30063P105 | EXK | Exact Sciences Corp | $2.6M | 0.20% | 37,637 | Common | SOLE |
| 254604101 | IRON | Disc Medicine Inc | $2.0M | 0.16% | 41,352 | Common | SOLE |
| 097702104 | BOLT1EUR | Bolt Biotherapeutics Inc | $1.8M | 0.14% | 2,754,437 | Common | SOLE |
| 86366E106 | GPCR | Structure Therapeutics Inc | $1.7M | 0.14% | 38,792 | Common | SOLE |
| 46489V302 | CATX | Perspective Therapeutics Inc | $1.6M | 0.13% | 120,632 | Common | SOLE |
| 05370A108 | RNAGBP | Avidity Biosciences Inc | $1.4M | 0.11% | 30,472 | Common | SOLE |
| 92764N102 | VIR | Vir Biotechnology Inc | $968,053 | 0.08% | 129,246 | Common | SOLE |
| 04635X102 | CATBUSD | Astria Therapeutics Inc | $942,896 | 0.07% | 85,640 | Common | SOLE |
| N44445117 | IMTXW | Immatics N.V | $852,271 | 0.07% | 366,568 | Common | SOLE |
| 45175G108 | — | Ikena Oncology Inc | $661,926 | 0.05% | 382,616 | Common | SOLE |
| 76029N106 | REPL | Replimune Group Inc | $527,592 | 0.04% | 48,138 | Common | SOLE |
| 745848101 | LUNG | Pulmonx Corp | $516,575 | 0.04% | 62,313 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.